Medtech funding is seeing momentum. The sector notched $4.1 billion in VC funding in Q1—the highest quarterly figure since early 2022—driven by growing interest in whole-body screening, smart diagnostics, and longevity platforms. Large rounds from Neko Health ($260 million) and Prenuvo ($120 million) underscored strong interest in consumer-facing diagnostics, while Function Health’s acquisition of Ezra showcased the growing convergence of medtech and digital health. PE deal flow also surged, with Q1 tracking well ahead of last year’s pace and PE backing companies such as Saluda Medical and OrganOx. On the exit front, medtech M&A is alive and well, with notable acquisitions by Boston Scientific and new planned spin-offs by Medtronic and BD.
Read the full article: PitchBook Q1 2025 Medtech VC and PE Trends //
Source: https://pitchbook.com/news/reports/q1-2025-medtech-vc-and-pe-trends